互联网+新型药学服务模式在医院支气管哮喘慢病管理中的实践与效果分析  

Practice and effect analysis of Internet plus new pharmaceutical care mode in management of chronic asthma in hospital

作　　者：赵均炎 乔进[1] 赵彦 ZHAO Jun-yan;QIAO Jin;ZHAO Yan(Nantong Third Hospital Affiliated to Nantong University,Nantong 226006,China)

机构地区：[1]南通大学附属南通第三医院,江苏南通226006

出　　处：《中国处方药》2023年第1期82-85,共4页Journal of China Prescription Drug

基　　金：江苏省药学会恒瑞医院药学基金(H202015)。

摘　　要：目的探讨互联网+新型药学服务模式在住院支气管哮喘患者中的应用与效果分析。方法选取医院呼吸内科2019年1月~2020年12月期间收治的支气管哮喘患者164例,其中2019年1~10月的82例作为对照组,给予常规的药学服务模式,2020年1~10月的82例作为观察组,给予互联网+新型药学服务模式。两组患者均干预6个月,对比两组患者的肺功能指标、患者吸入治疗的依从性、哮喘吸入装置的正确使用率、干预期间两组患者不良反应的发生情况及哮喘复发情况。结果两组患者分别干预6个月后,肺功能指标均得到不同程度的改善,观察组患者的肺功能指标(FEV_(1)、FEV_(1)/FVC与PEF)较对照组患者改善显著(P<0.05);观察组患者吸入治疗总的依从性与吸入装置的正确使用率均高于对照组患者(均P<0.05);观察组患者吸入治疗期间的不良反应发生率显著低于对照组患者(均P<0.05);观察组患者在接受干预期间的哮喘复发情况(复发率、急性发作次数及再入院次数)均显著低于对照组患者(均P<0.05)。结论互联网+新型药学服务模式在支气管哮喘患者中的成功应用,能有效改善支气管哮喘患者的肺功能,提高用药依从性并降低用药不良反应与复发情况。Objective To explore the application and effect of Internet plus new pharmaceutical care mode in hospitalized patients with bronchial asthma.Methods 164 cases of bronchial asthma were selected in the respiratory department of the hospital from January 2019 to December in 2020,and 82 cases from January to October in 2019 were selected as the control group.The routine pharmaceutical care mode was adopted.82 cases from January to October in 2020 were selected as the observation group,and the Internet plus new pharmaceutical service mode was given.The two groups were intervened for 6 months.The pulmonary function indexes,the compliance of patients with inhalation treatment,the correct use rate of asthma inhalation device,the incidence of adverse reactions and asthma recurrence of the two groups during the intervention were compared.Results After 6 months of intervention,the pulmonary function indexes of the two groups were improved in varying degrees,but the pulmonary function indexes(FEV_(1),FEV_(1)/FVC and PEF)of the observation group were significantly improved than those of the control group(P<0.05);The total compliance of inhalation treatment and the correct use rate of inhalation device in the observation group were higher than those in the control group(all P<0.05);The incidence of adverse reactions in the observation group was significantly lower than that in the control group(all P<0.05);The recurrence of asthma(recurrence rate,number of acute attacks and readmission times)in the observation group were significantly lower than those in the control group(all P<0.05).Conclusion The Internet plus new pharmaceutical care mode can successfully improve the lung function of bronchial asthma patients,improve their medication compliance and reduce their adverse reactions.

关 键 词：互联网+ 新型药学服务 支气管哮喘 慢病管理 

分 类 号：R562.25[医药卫生—呼吸系统]